PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,325,366 | -20.6% | 2,935,660 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $38,173,252 | +26.2% | 2,911,766 | +7.6% | 0.00% | 0.0% |
| Q1 2023 | $30,252,464 | +33.2% | 2,705,945 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $22,707,386 | -44.8% | 2,693,640 | +9.1% | 0.00% | 0.0% |
| Q3 2022 | $41,122,000 | +14.9% | 2,468,285 | +1.6% | 0.00% | 0.0% |
| Q2 2022 | $35,776,000 | -47.8% | 2,430,317 | -11.9% | 0.00% | -50.0% |
| Q1 2022 | $68,477,000 | -21.5% | 2,760,055 | +1.5% | 0.00% | 0.0% |
| Q4 2021 | $87,177,000 | -11.5% | 2,718,331 | -0.7% | 0.00% | -33.3% |
| Q3 2021 | $98,508,000 | -3.9% | 2,737,819 | +17.8% | 0.00% | 0.0% |
| Q2 2021 | $102,520,000 | +144.5% | 2,323,639 | +153.4% | 0.00% | +200.0% |
| Q1 2021 | $41,939,000 | -28.6% | 916,921 | +7.8% | 0.00% | -50.0% |
| Q4 2020 | $58,708,000 | – | 850,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |